Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares Repurchased
Ratios

Delcath Systems (DCTH) Long-Term Debt Issuances (2016 - 2019)

Delcath Systems' quarterly Long-Term Debt Issuances came in at $3.3 million in Q2 2019, up 52.81% year-on-year from $2.2 million in Q2 2018, and up 729.75% quarter-over-quarter from $400000.0 in Q1 2019.

Delcath Systems has reported Long-Term Debt Issuances for 3 years, with the latest figure at $3.3 million in Q2 2019.

  • For the quarter ending Q2 2019, Long-Term Debt Issuances rose 52.81% year-over-year to $3.3 million; the trailing twelve-month figure through Mar 2020 stood at $3.3 million (up 729.75% YoY), and the FY2019 full-year result was $3.7 million, changed N/A from the prior year.
  • Long-Term Debt Issuances for Q2 2019 stood at $3.3 million, up from $400000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $3.3 million in Q2 2019, with the low at -$2.2 million in Q3 2018.
  • Average Long-Term Debt Issuances over 3 years is $570333.3, with a median of $156500.0 recorded in 2016.
  • Peak annual rise in Long-Term Debt Issuances reached 52.81% in 2019, while the deepest fall reached 52.81% in 2019.
  • Tracing DCTH's Long-Term Debt Issuances over 3 years: stood at -$210000.0 in 2016, then plunged by 934.29% to -$2.2 million in 2018, then jumped by 252.81% to $3.3 million in 2019.
  • The last three Long-Term Debt Issuances figures came in at $3.3 million (Q2 2019), $400000.0 (Q1 2019), and -$2.2 million (Q3 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 19.86 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 11.71 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.15 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Delcath Systems 383.27 Mn 293.95 Mn 21.26 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2019 3.32 Mn
Jun 30, 2019 3.32 Mn
Mar 31, 2019 400,000.00
Mar 31, 2019 400,000.00
Sep 30, 2018 -2.17 Mn
Sep 30, 2018 -2.17 Mn
Jun 30, 2018 2.17 Mn
Jun 30, 2018 2.17 Mn
Dec 31, 2016 -210,000.00
Dec 31, 2016 -210,000.00
Sep 30, 2016 -87,000.00
Sep 30, 2016 -87,000.00